Investor Relations

NYSE: TDOC -0.26 -2.62%
Volume: 2,149,521
20 minute delay July 16, 2026

Teladoc Health is the global leader in virtual care.

We are transforming how better health happens.

Teladoc Health is delivering and orchestrating care across patients, care providers, platforms, and partners for more complete and personalized care. Through our technology, services and clinical expertise, we equip care teams to perform at their highest caliber and address comprehensive health needs – physical and mental, simple and complex, urgent and ongoing. By applying the power of technology and insights, we elevate care experiences and make moments of care more impactful. We work with health plans, employers, health systems, and partners around the world to unlock access and outcomes at unmatched scale, helping millions of people live their healthiest lives.

Investor Events

Investor News

July 15, 2026
Teladoc Health to Announce Second Quarter 2026 Financial Results
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) - Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 833-461-5787 for U.S. participants and using the meeting ID # 478 236 923. For international participants, please visit the following link for global dial-in numbers, using the same meeting ID # 478 236 923: https://help.events.q4inc.com/eahc/international-dial-in-numbers . A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/ . A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. About...
Read More
July 3, 2026
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of BetterHelp, David Packles was granted an award of restricted stock units covering 50,000 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The award was approved by the Compensation Committee of the Board of Directors of Teladoc Health and was granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as an employment inducement award pursuant to New York Stock Exchange Rule 303A.08. About Teladoc Health
Teladoc Health (NYSE:...
Read More

Get in touch today

Contact Teladoc Health Investor Relations

Michael Minchak | Vice President, Investor Relations | IR@teladochealth.com